Gynecomastia-the enlargement of male breast tissue in men-is a common finding, frequently observed in newborns, adolescents, and old men. Physiological gynecomastia, occurring in almost 25 % of cases, is benign and self-limited; on the other hand, several conditions and drugs may induce proliferation of male breast tissue. True gynecomastia is a common feature often related to estrogen excess and/or androgen deficiency as a consequence of different endocrine disorders. Biochemical evaluation should be performed once physiological or iatrogenic gynecomastia has been ruled out. Non-endocrine illnesses, including liver failure and chronic kidney disease, are another cause of gynecomastia which should be considered. Treating the underlying disease or discontinuing medications might resolve gynecomastia, although the psychosocial burden of this condition might require different and careful consideration

Gynecomastia and hormones / Sansone, Andrea; Romanelli, Francesco; Sansone, Massimiliano; Lenzi, Andrea; Di Luigi, L.. - In: ENDOCRINE. - ISSN 1559-0100. - STAMPA. - 55:1(2017), pp. 37-44. [10.1007/s12020-016-0975-9]

Gynecomastia and hormones

SANSONE, ANDREA
;
ROMANELLI, Francesco;SANSONE, MASSIMILIANO;LENZI, Andrea;
2017

Abstract

Gynecomastia-the enlargement of male breast tissue in men-is a common finding, frequently observed in newborns, adolescents, and old men. Physiological gynecomastia, occurring in almost 25 % of cases, is benign and self-limited; on the other hand, several conditions and drugs may induce proliferation of male breast tissue. True gynecomastia is a common feature often related to estrogen excess and/or androgen deficiency as a consequence of different endocrine disorders. Biochemical evaluation should be performed once physiological or iatrogenic gynecomastia has been ruled out. Non-endocrine illnesses, including liver failure and chronic kidney disease, are another cause of gynecomastia which should be considered. Treating the underlying disease or discontinuing medications might resolve gynecomastia, although the psychosocial burden of this condition might require different and careful consideration
2017
Estradiol; Gynecomastia; Hyperprolactinemia; Hyperthyroidism; Hypogonadism; Male breast enlargement; Testosterone
01 Pubblicazione su rivista::01a Articolo in rivista
Gynecomastia and hormones / Sansone, Andrea; Romanelli, Francesco; Sansone, Massimiliano; Lenzi, Andrea; Di Luigi, L.. - In: ENDOCRINE. - ISSN 1559-0100. - STAMPA. - 55:1(2017), pp. 37-44. [10.1007/s12020-016-0975-9]
File allegati a questo prodotto
File Dimensione Formato  
Sansone_Gynecomastia_2017.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 730.44 kB
Formato Adobe PDF
730.44 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/870451
Citazioni
  • ???jsp.display-item.citation.pmc??? 28
  • Scopus 68
  • ???jsp.display-item.citation.isi??? 57
social impact